Finalizing the WHO Pandemic Agreement's Pathogen Access and Benefit Sharing annex: A Call to Action (2026)

The Pandemic Promise: Why the World Can’t Afford to Stall on Pathogen Sharing

The world is at a crossroads, and it’s not one we haven’t seen before. In the wake of a pandemic that upended lives, economies, and our collective sense of security, humanity made a promise: never again. Yet, as I reflect on the open letter from Brazilian President Luiz Inácio Lula da Silva and WHO Director-General Tedros Adhanom Ghebreyesus, I’m struck by how fragile that promise remains. The WHO Pandemic Agreement, a beacon of global cooperation, is incomplete without the Pathogen Access and Benefit-Sharing (PABS) annex. And here’s the kicker: without it, we’re essentially leaving the door open for the next pandemic.

What’s at Stake? More Than Just a Legal Document

Let’s be clear: the PABS annex isn’t just bureaucratic jargon. It’s the linchpin for a system that could save millions of lives. Personally, I think what makes this particularly fascinating is how it boils down to a simple yet profound idea: sharing pathogens early and equitably means we can develop vaccines and treatments faster. But here’s where it gets complicated—and interesting. The annex isn’t just about science; it’s about trust, equity, and political will. What many people don’t realize is that the hardest part isn’t the science itself but the negotiations around who gets what and when.

From my perspective, the core issue is equity. When a country shares a dangerous pathogen, they’re essentially handing over the key to stopping a potential pandemic. But what’s in it for them? The PABS system promises that the vaccines and treatments developed from that sharing will be accessible to everyone, not just the wealthiest nations. This isn’t charity—it’s strategy. If you take a step back and think about it, containing a virus at its source is far cheaper and more effective than fighting a global pandemic. Yet, the current system is patchwork, improvised, and unpredictable. The PABS annex offers a stable framework, but only if leaders prioritize it.

The Political Will Gap: Why Leaders Need to Step Up

One thing that immediately stands out is the call for political will. Technical experts can only do so much; the remaining hurdles require leaders to make bold choices. What this really suggests is that the PABS annex isn’t just a technical issue—it’s a test of global solidarity. In my opinion, the reluctance to finalize it isn’t about science or logistics; it’s about power dynamics and national interests. The letter rightly points out that the Pandemic Agreement doesn’t compromise state sovereignty, but some leaders seem to view it as a zero-sum game.

Here’s where I think the commentary gets interesting: the PABS annex isn’t about giving up control; it’s about gaining collective control over pandemics. What many people misunderstand is that sovereignty isn’t threatened by cooperation—it’s enhanced by it. A virus doesn’t respect borders, and neither should our response. Yet, the negotiations have stalled because of fears over who benefits and how. This raises a deeper question: are we willing to let short-term national interests overshadow long-term global survival?

Equity as Strategy: Why Fairness Isn’t Just Moral, It’s Practical

A detail that I find especially interesting is the emphasis on equity as a strategic imperative. During Brazil’s G20 presidency, the country highlighted inequality as a driver of pandemics. This isn’t just a moral argument; it’s a practical one. When vaccines and treatments are hoarded by wealthy nations, the virus continues to spread in underserved regions, mutating and threatening everyone. What this really suggests is that equity isn’t a cost—it’s an investment in global health security.

But here’s the catch: equity needs to be baked into the operational details of the PABS annex, not just its preamble. It’s easy to pay lip service to fairness, but the devil is in the details. How will benefits be shared? How will we ensure that low-income countries aren’t left behind? These questions aren’t just technical; they’re political. And they require leaders to choose solidarity over self-interest.

The Clock Is Ticking: Why July 17th Isn’t Just Another Deadline

The next pandemic isn’t a matter of if, but when. Scientists estimate a one in four chance of another pandemic within the next decade. Climate change, urbanization, and biotechnology are reshaping the landscape of pathogen emergence. What makes this particularly alarming is that the next hotspot could be anywhere—even in the heart of a G7 nation. Yet, we’re treating the July negotiations like just another meeting.

In my opinion, this lack of urgency is baffling. The last pandemic cost the world over 13 trillion dollars and up to 20 million lives. Against that backdrop, finalizing the PABS annex is a no-brainer. Yet, every month of delay leaves us vulnerable. What this really suggests is that we’re not just negotiating a document; we’re negotiating our future.

The Legacy We Leave: A Promise Kept or Broken?

As I reflect on the letter’s closing lines, I’m struck by the weight of history. Humanity has faced pandemics before, and we’ve emerged stronger. We eradicated smallpox, pushed polio to the brink, and turned the tide against HIV. Finalizing the Pandemic Agreement isn’t a departure from that legacy—it’s the next chapter.

But here’s the thing: legacies aren’t built on promises; they’re built on actions. The PABS annex is within reach, but it requires leaders to choose courage over caution, solidarity over self-interest, and urgency over complacency. Personally, I think this is our moment to prove that the lessons of COVID-19 weren’t learned in vain.

So, to the leaders of the G7, G20, BRICS, and all nations: the world is watching. The promise you made isn’t just to the millions lost to COVID-19—it’s to the billions who could be lost to the next pandemic. Will you keep it?